Form 8-K - Current report:
SEC Accession No. 0001104659-25-027504
Filing Date
2025-03-25
Accepted
2025-03-25 06:50:17
Documents
15
Period of Report
2025-03-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2510115d1_8k.htm   iXBRL 8-K 28572
2 EXHIBIT 99.1 tm2510115d1_ex99-1.htm EX-99.1 66634
3 GRAPHIC tm2510115d1_ex99-1img001.jpg GRAPHIC 2676
  Complete submission text file 0001104659-25-027504.txt   284982

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA zura-20250325.xsd EX-101.SCH 3012
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zura-20250325_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zura-20250325_pre.xml EX-101.PRE 22357
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2510115d1_8k_htm.xml XML 3804
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40598 | Film No.: 25765760
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)